// App-Quantinova.ai

: Developing a novel biologic for the treatment of high-risk B cell acute lymphoblastic leukemia (P1117)

Researchers

Presenter

  • Caleb Ruiz-Jimnez

Principal Investigators

  • Jacqueline Coats

  • Xianmei Meng

  • Cornelia Stoian

  • Ineavely Baez

  • Hossam AlKashgari

  • Andy Paz-Aldana

  • Sarah Doublet

  • Hannah Choi

  • Roland Williams

  • Shadi Farzin-Gohar

  • Sinisa Dovat

  • Kimberly J Payne

Medical Centers

  • Loma Linda Univ, CA

  • Elf Zone,

  • Pennsylvania State Univ. Col. of Med.

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • Peptidase inhibitor 3

  • Janus kinase

  • Serine/threonine-protein kinase mTOR

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved